Compliance Policy Guide on Crabmeat-Fresh and Frozen-Adulteration With Filth, Involving the Presence of Escherichia coli, 25408-25409 [2016-09951]
Download as PDF
25408
Federal Register / Vol. 81, No. 82 / Thursday, April 28, 2016 / Notices
and Services Program, 330 C Street SW.,
3rd Floor, Suite 3621B, Washington, DC
20201. Telephone: 202–401–5524;
Email: Angela.Yannelli@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Hotline in Austin, TX, is funded under
the Family Violence Protection and
Services Act (FVPSA) program to
operate the 24-hour, national, toll-free
telephone hotline that provides
information and assistance to adult and
youth victims of family violence,
domestic violence, or dating violence,
and to the family and household
members of such victims, and to
persons affected by the victimization.
The supplemental award will expand
the capacity of the Hotline’s current
efforts by focusing on the development
of a tribal hotline and by providing
additional phone advocates to ensure
that the Hotline can answer all contacts.
The award will also assist in developing
the ‘‘Love Is Respect’’ Web site (https://
www.loveisrespect.org) into a complete
resource for teens and youth seeking to
prevent and end abusive relationships.
Statutory Authority: The statutory
authority for the award is section 313 of the
Family Violence Prevention and Services Act
(42 U.S.C. 10413) as amended by section 201
of the CAPTA Reauthorization Act of 2010
(Pub. L. 111–320).
Christopher Beach,
Senior Grants Policy Specialist, Division of
Grants Policy, Office of Administration,
Administration for Children and Families.
[FR Doc. 2016–09925 Filed 4–27–16; 8:45 am]
BILLING CODE 4184–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–1842]
Compliance Policy Guide on
Crabmeat—Fresh and Frozen—
Adulteration With Filth, Involving the
Presence of Escherichia coli
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a
Compliance Policy Guide (CPG) relating
to fresh and frozen crabmeat
adulteration with filth involving the
presence of Escherichia coli (E. coli).
The CPG updates the previously issued
CPG on this topic. The CPG provides
guidance for FDA staff on the level of E.
coli in crabmeat at which we may
consider the crabmeat to be adulterated
with filth.
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
22:09 Apr 27, 2016
Jkt 238001
Submit electronic or written
comments on FDA’s CPGs at any time.
ADDRESSES: You may submit comments
as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2014–D–1842 for ‘‘Compliance Policy
Guide on Crabmeat—Fresh and
Frozen—Adulteration with Filth,
Involving the Presence of Escherichia
coli.’’ Received comments will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Division of Dockets
Management. If you do not wish your
name and contact information to be
made publicly available, you can
provide this information on the cover
sheet and not in the body of your
comments and you must identify this
information as ‘‘confidential.’’ Any
information marked as ‘‘confidential’’
will not be disclosed except in
accordance with 21 CFR 10.20 and other
applicable disclosure law. For more
information about FDA’s posting of
comments to public dockets, see 80 FR
56469, September 18, 2015, or access
the information at: https://www.fda.gov/
regulatoryinformation/dockets/
default.htm.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
Submit written requests for single
copies of the guidance to Office of
Policy and Risk Management, Office of
Regulatory Affairs, Office of Global
Regulatory Operations and Policy, Food
and Drug Administration, 12420
Parklawn Dr., Rockville, MD 20857.
Send two self-addressed adhesive labels
to assist that office in processing your
request. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance.
FOR FURTHER INFORMATION CONTACT:
Mary E. Losikoff, Center for Food Safety
and Applied Nutrition (HFC–820), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740,
240–402–2300.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28APN1.SGM
28APN1
mstockstill on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 81, No. 82 / Thursday, April 28, 2016 / Notices
I. Background
We are announcing the availability of
revised CPG Sec. 540.275 Crabmeat—
Fresh and Frozen—Adulteration with
Filth, Involving the Presence of
Escherichia coli. The CPG updates the
previously issued CPG Sec. 540.275
Crabmeat—Fresh and Frozen—
Adulteration with Filth, Involving the
Presence of Escherichia coli. We are
issuing this CPG consistent with our
good guidance practices regulation (21
CFR 10.115). The CPG represents the
current thinking of FDA on this topic.
It does not establish any rights for any
person and is not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations.
The CPG provides guidance for FDA
staff on the level of E. coli in fresh or
frozen crabmeat (i.e., 3.6 Most Probable
Number per gram (MPN/g) of E. coli) at
which FDA may consider the crabmeat
to be adulterated with filth under
section 402(a)(4) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C.
342(a)(4)). We revised the CPG for
clarity and to update the format.
Revisions generally include the addition
of sections on Background and Policy,
updates to the sections on Regulatory
Action Guidance and Specimen
Charges, and FDA office names. The
CPG provides criteria that the FDA
District Offices may use to determine
whether to recommend an enforcement
action. Consistent with our standard
business process, the CPG provides
guidance to the FDA field offices for
submitting an enforcement action
recommendation to FDA’s Center for
Food Safety and Applied Nutrition
(CFSAN) for case review. The CPG also
provides direct reference authority to
the FDA field offices in certain
situations. Rather than submitting the
recommendation to CFSAN, direct
reference authority allows the FDA field
offices to submit the recommendation
directly to the appropriate office in
FDA’s Office of Regulatory Affairs, thus
streamlining the Agency’s internal case
review process. Specifically, in the
section on Regulatory Action Guidance,
we clarify that FDA’s District Offices
have direct reference authority for both
domestic seizure and import refusal
based on the criteria described in the
CPG. We also clarify the specific types
of legal action to which the criteria for
recommendations apply. In addition, we
provide specimen charges relating to
domestic seizure and import refusal.
The CPG also contains information that
may be useful to the regulated industry
and to the public.
VerDate Sep<11>2014
22:09 Apr 27, 2016
Jkt 238001
In the Federal Register of December
16, 2014 (79 FR 74729), we made
available draft CPG Sec. 540.275
‘‘Crabmeat—Fresh and Frozen—
Adulteration with Filth, Involving the
Presence of Escherichia coli.’’ We gave
interested parties an opportunity to
submit comments on the draft CPG by
February 17, 2015, for us to consider
before beginning work on the final
version of the CPG. We received no
comments on the draft CPG. We are
issuing the CPG with no changes other
than for clarity and to update the
format. The CPG announced in this
notice finalizes the draft CPG dated
December 2014.
II. Electronic Access
Persons with access to the Internet
may obtain the CPG at either https://
www.fda.gov/ICECI/Compliance
Manuals/CompliancePolicyGuidance
Manual/default.htm or https://
www.regulations.gov. Use the FDA Web
site listed in the previous sentence to
find the most current version of the
CPG.
Dated: April 25, 2016.
Katherine Bent,
Assistant Commissioner for Compliance
Policy.
[FR Doc. 2016–09951 Filed 4–27–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0557]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Postmarket
Surveillance
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
information collection requirements for
postmarket surveillance of medical
devices.
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
25409
Submit either electronic or
written comments on the collection of
information by June 27, 2016.
ADDRESSES: You may submit comments
as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2013–N–0557 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request;
Postmarket Surveillance.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
• Confidential Submissions—To
submit a comment with confidential
E:\FR\FM\28APN1.SGM
28APN1
Agencies
[Federal Register Volume 81, Number 82 (Thursday, April 28, 2016)]
[Notices]
[Pages 25408-25409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09951]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-D-1842]
Compliance Policy Guide on Crabmeat--Fresh and Frozen--
Adulteration With Filth, Involving the Presence of Escherichia coli
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
availability of a Compliance Policy Guide (CPG) relating to fresh and
frozen crabmeat adulteration with filth involving the presence of
Escherichia coli (E. coli). The CPG updates the previously issued CPG
on this topic. The CPG provides guidance for FDA staff on the level of
E. coli in crabmeat at which we may consider the crabmeat to be
adulterated with filth.
DATES: Submit electronic or written comments on FDA's CPGs at any time.
ADDRESSES: You may submit comments as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2014-D-1842 for ``Compliance Policy Guide on Crabmeat--Fresh and
Frozen--Adulteration with Filth, Involving the Presence of Escherichia
coli.'' Received comments will be placed in the docket and, except for
those submitted as ``Confidential Submissions,'' publicly viewable at
https://www.regulations.gov or at the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.fda.gov/regulatoryinformation/dockets/default.htm.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
Submit written requests for single copies of the guidance to Office
of Policy and Risk Management, Office of Regulatory Affairs, Office of
Global Regulatory Operations and Policy, Food and Drug Administration,
12420 Parklawn Dr., Rockville, MD 20857. Send two self-addressed
adhesive labels to assist that office in processing your request. See
the SUPPLEMENTARY INFORMATION section for electronic access to the
guidance.
FOR FURTHER INFORMATION CONTACT: Mary E. Losikoff, Center for Food
Safety and Applied Nutrition (HFC-820), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740, 240-402-2300.
SUPPLEMENTARY INFORMATION:
[[Page 25409]]
I. Background
We are announcing the availability of revised CPG Sec. 540.275
Crabmeat--Fresh and Frozen--Adulteration with Filth, Involving the
Presence of Escherichia coli. The CPG updates the previously issued CPG
Sec. 540.275 Crabmeat--Fresh and Frozen--Adulteration with Filth,
Involving the Presence of Escherichia coli. We are issuing this CPG
consistent with our good guidance practices regulation (21 CFR 10.115).
The CPG represents the current thinking of FDA on this topic. It does
not establish any rights for any person and is not binding on FDA or
the public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations.
The CPG provides guidance for FDA staff on the level of E. coli in
fresh or frozen crabmeat (i.e., 3.6 Most Probable Number per gram (MPN/
g) of E. coli) at which FDA may consider the crabmeat to be adulterated
with filth under section 402(a)(4) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 342(a)(4)). We revised the CPG for clarity and
to update the format. Revisions generally include the addition of
sections on Background and Policy, updates to the sections on
Regulatory Action Guidance and Specimen Charges, and FDA office names.
The CPG provides criteria that the FDA District Offices may use to
determine whether to recommend an enforcement action. Consistent with
our standard business process, the CPG provides guidance to the FDA
field offices for submitting an enforcement action recommendation to
FDA's Center for Food Safety and Applied Nutrition (CFSAN) for case
review. The CPG also provides direct reference authority to the FDA
field offices in certain situations. Rather than submitting the
recommendation to CFSAN, direct reference authority allows the FDA
field offices to submit the recommendation directly to the appropriate
office in FDA's Office of Regulatory Affairs, thus streamlining the
Agency's internal case review process. Specifically, in the section on
Regulatory Action Guidance, we clarify that FDA's District Offices have
direct reference authority for both domestic seizure and import refusal
based on the criteria described in the CPG. We also clarify the
specific types of legal action to which the criteria for
recommendations apply. In addition, we provide specimen charges
relating to domestic seizure and import refusal. The CPG also contains
information that may be useful to the regulated industry and to the
public.
In the Federal Register of December 16, 2014 (79 FR 74729), we made
available draft CPG Sec. 540.275 ``Crabmeat--Fresh and Frozen--
Adulteration with Filth, Involving the Presence of Escherichia coli.''
We gave interested parties an opportunity to submit comments on the
draft CPG by February 17, 2015, for us to consider before beginning
work on the final version of the CPG. We received no comments on the
draft CPG. We are issuing the CPG with no changes other than for
clarity and to update the format. The CPG announced in this notice
finalizes the draft CPG dated December 2014.
II. Electronic Access
Persons with access to the Internet may obtain the CPG at either
https://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/default.htm or https://www.regulations.gov. Use the FDA Web site listed in the previous
sentence to find the most current version of the CPG.
Dated: April 25, 2016.
Katherine Bent,
Assistant Commissioner for Compliance Policy.
[FR Doc. 2016-09951 Filed 4-27-16; 8:45 am]
BILLING CODE 4164-01-P